NO303730B1 - Antimikrobielle karbapenemderivater - Google Patents

Antimikrobielle karbapenemderivater

Info

Publication number
NO303730B1
NO303730B1 NO930884A NO930884A NO303730B1 NO 303730 B1 NO303730 B1 NO 303730B1 NO 930884 A NO930884 A NO 930884A NO 930884 A NO930884 A NO 930884A NO 303730 B1 NO303730 B1 NO 303730B1
Authority
NO
Norway
Prior art keywords
hydrogen
carbapenem derivatives
antimicrobial
useful
antimicrobial carbapenem
Prior art date
Application number
NO930884A
Other languages
English (en)
Other versions
NO930884L (no
NO930884D0 (no
Inventor
Isao Kawamoto
Rokuro Endo
Masao Miyauchi
Katsuya Ishikawa
Katsuhiko Watanabe
Hiroshi Yasuda
Satoshi Ohya
Yukio Utsui
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO930884D0 publication Critical patent/NO930884D0/no
Publication of NO930884L publication Critical patent/NO930884L/no
Publication of NO303730B1 publication Critical patent/NO303730B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO930884A 1992-03-11 1993-03-11 Antimikrobielle karbapenemderivater NO303730B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP5216392 1992-03-11
JP24495392 1992-09-14
JP24657892 1992-09-16

Publications (3)

Publication Number Publication Date
NO930884D0 NO930884D0 (no) 1993-03-11
NO930884L NO930884L (no) 1993-09-13
NO303730B1 true NO303730B1 (no) 1998-08-24

Family

ID=27294566

Family Applications (1)

Application Number Title Priority Date Filing Date
NO930884A NO303730B1 (no) 1992-03-11 1993-03-11 Antimikrobielle karbapenemderivater

Country Status (19)

Country Link
EP (1) EP0560613B1 (no)
KR (1) KR100258225B1 (no)
CN (1) CN1037180C (no)
AT (1) ATE173733T1 (no)
AU (1) AU664422B2 (no)
CA (1) CA2091486A1 (no)
CZ (1) CZ290002B6 (no)
DE (1) DE69322188T2 (no)
DK (1) DK0560613T3 (no)
ES (1) ES2125945T3 (no)
FI (1) FI103046B (no)
HK (1) HK1011976A1 (no)
HU (1) HU218676B (no)
IL (1) IL105020A (no)
MX (1) MX9301361A (no)
NO (1) NO303730B1 (no)
NZ (1) NZ247129A (no)
RU (1) RU2097383C1 (no)
TW (1) TW249803B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI101226B (fi) * 1991-06-04 1998-05-15 Sankyo Co Menetelmä lääkeaineena käyttökelpoisten 2-£2-(karbonyyli)pyrrolidin-4- yylitio|-6-(1-hydroksietyyli)-1-metyylikarbapen-2-eemi-3-karboksyyliha ppojohdannaisten valmistamiseksi
GB9515975D0 (en) 1995-08-04 1995-10-04 Zeneca Ltd Chemical compounds
HUP9901376A3 (en) * 1995-12-21 2000-03-28 Sankyo Company Ltd Chuo Ku 1-methylcarbapenem derivatives, their use, production thereof and medicaments containing the same
CZ342098A3 (cs) * 1996-04-26 1999-02-17 Sankyo Company, Limited 1-Methylkarbapenemové deriváty
EP0923545A1 (en) 1996-08-17 1999-06-23 Zeneca Limited 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors
AU1415500A (en) * 1998-12-07 2000-06-26 Sankyo Company Limited 1-methylcarbapenem derivatives
US7041660B2 (en) 1999-07-06 2006-05-09 Sankyo Company, Limited Crystalline 1-methylcarbapenem derivatives
GB9930318D0 (en) 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
GB9930317D0 (en) 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
JP4480396B2 (ja) * 2001-09-26 2010-06-16 メルク・シャープ・エンド・ドーム・コーポレイション カルバペネム化合物の製造方法
JP4792974B2 (ja) * 2003-12-25 2011-10-12 小野薬品工業株式会社 アゼチジン環化合物およびその医薬
CN101367814B (zh) * 2007-06-28 2010-12-15 山东轩竹医药科技有限公司 被巯基吡咯烷甲酰哌啶取代的培南衍生物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
DE3780344T2 (de) * 1986-03-27 1993-01-28 Sumitomo Pharma Beta-lactam-verbindungen und deren herstellung.
CA2036163C (en) * 1990-02-14 2001-06-19 Makoto Sunagawa Novel beta-lactam compounds and their production
FI96863C (fi) * 1990-02-23 1996-09-10 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten /2-(1-homopiperatsiinikarbonyyli)pyrrolidin-4-yylitio/-6-(1-hydroksietyyli)-1-karbapen-2-eemi-3-karboksylaattisuolojen valmistamiseksi
GB9107363D0 (en) * 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
FI101226B (fi) * 1991-06-04 1998-05-15 Sankyo Co Menetelmä lääkeaineena käyttökelpoisten 2-£2-(karbonyyli)pyrrolidin-4- yylitio|-6-(1-hydroksietyyli)-1-metyylikarbapen-2-eemi-3-karboksyyliha ppojohdannaisten valmistamiseksi
CA2117899A1 (en) * 1992-04-13 1993-10-28 Masayoshi Murata Substituted 3-pyrrolidinylthio-carbapenems as antimicrobial agents

Also Published As

Publication number Publication date
FI931079A (fi) 1993-09-12
CN1079472A (zh) 1993-12-15
IL105020A0 (en) 1993-07-08
HUT64071A (en) 1993-11-29
AU3515193A (en) 1993-09-16
NO930884L (no) 1993-09-13
FI103046B1 (fi) 1999-04-15
RU2097383C1 (ru) 1997-11-27
FI931079A0 (fi) 1993-03-10
EP0560613A1 (en) 1993-09-15
FI103046B (fi) 1999-04-15
NZ247129A (en) 1994-09-27
EP0560613B1 (en) 1998-11-25
MX9301361A (es) 1994-01-31
NO930884D0 (no) 1993-03-11
HU218676B (hu) 2000-10-28
HK1011976A1 (en) 1999-07-23
AU664422B2 (en) 1995-11-16
DE69322188D1 (de) 1999-01-07
CZ39393A3 (en) 1993-12-15
DK0560613T3 (da) 1999-08-09
CA2091486A1 (en) 1993-09-12
ES2125945T3 (es) 1999-03-16
KR100258225B1 (ko) 2000-08-01
HU9300677D0 (en) 1993-05-28
CZ290002B6 (cs) 2002-05-15
IL105020A (en) 1997-04-15
CN1037180C (zh) 1998-01-28
KR930019674A (ko) 1993-10-18
TW249803B (no) 1995-06-21
DE69322188T2 (de) 1999-07-29
ATE173733T1 (de) 1998-12-15

Similar Documents

Publication Publication Date Title
DE69319976T2 (de) 7-Substituierte-9-substituierte Glycylamido-6-Demethyl-6-Deoxytetracycline
ATE215530T1 (de) 7-substituierte-8-substituierte-9-substituierte amino-7-demethyl-6-deoxy-tetracycline als antibiotische mittel
TW269678B (no)
PT618190E (pt) 9-¬glicil substituido)amido|-6-(substituido)-5-hidroxi-6-desoxitetraciclinas
IL110151A0 (en) Amide and urea derivatives and pharmaceutical compositions containing the same
IL146476A0 (en) Heterocyclic substituted aminoazacycles useful as central nervous system agents
NO303730B1 (no) Antimikrobielle karbapenemderivater
RU93004678A (ru) Противомикробные производные карбапенема, способы их получения и применение
ES8703456A1 (es) Procedimiento para preparar derivados de nitrofurano
JPS5681518A (en) Composition and treatment
TR199701286T1 (xx) Karbapenemlerin esterleri.
AU6029090A (en) Improvements in or relating to organic compounds
TH13812EX (th) อนุพันธ์ของคาร์บาพีเนมต่อต้านจุลินทรีย์, การ เตรียมสารเหล่านั้นและการใช้สารเหล่านั้นในการ รักษา
DE59300004D1 (de) 2,3-Dihydroxychinoxalinverbindungen.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN SEPTEMBER 2003